ArticleOncology letters2021

Synergistic antitumor effect of the anti-ErbB2 antibodies trastuzumab and H2-18 on trastuzumab-resistant gastric cancer cells.

Chao Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.